L

Louisiana Heart Center | Slidell, LA

Research site
(Unclaimed)
Location
1810 Linberg Drive, Suite 2100, Slidell, Louisiana, United States of America
Site insights

Top conditions

Acute Coronary Syndrome (3 trials)

Myocardial Ischemia (2 trials)

Infarction (2 trials)

Myocardial Infarction (2 trials)

Atrial Fibrillation (2 trials)

Top treatments

Apixaban
Obicetrapib
Milvexian
Iron
Evolocumab
BMS-512148
IONIS-AGT-LRx
Ranolazine
Dapagliflozin

Parent organization

This site is a part of Louisiana Heart Center

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Other: Placebo
Drug: Milvexian

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Enrolling
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Obicetrapib

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Trial sponsors

Amgen logo

Amgen (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems